Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physiological Responses to Formoterol and Symbicort in Well-Trained Individuals
NCT06105671Completed
- Start
- Jan 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of formoterol in asthma (5 arms). Primary endpoint: Power output during time trial at 4 weeks. Started Jan 2024; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06105671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06105671.